AI Article Synopsis

  • Liddle syndrome is a genetic form of hypertension caused by mutations in the subunits of epithelial sodium channels (ENaCs), characterized by high blood pressure, low potassium levels, and altered hormone activity.
  • A novel frame-shift mutation was identified in the β subunit of ENaC (c.1691_1693delinsG) in a Chinese family, affecting the function of these channels and leading to variability in symptoms among family members.
  • The study emphasizes the importance of genetic analysis for accurate diagnosis and treatment, as clinical symptoms alone can be misleading due to the phenotypic diversity in affected individuals.

Article Abstract

Background: Liddle syndrome is a form of monogenic hypertension caused by mutations in the three homologous subunits of the epithelial sodium channels (ENaCs), α, β, and γ. It is characterized by early-onset refractory hypertension, hypokalemia, low renin activity, and hypoaldosteronism. In this study, we report a novel frame-shift mutation in responsible for Liddle syndrome in a Chinese family.

Methods: DNA samples were collected from all participants. Whole-exome sequencing was performed in the proband to detect possible causative variants. Sanger sequencing was then conducted in the other family members to verify the candidate variant, and in 100 patients with hypertension and 100 normotensive controls to exclude population genetic polymorphism.

Results: We identified a novel frame-shift mutation (c.1691_1693delinsG) in that was responsible for Liddle syndrome in this family. This mutation leads to the substitution of Arg in place of Gln at codon site 564 and generates a new stop codon at 592, influencing the crucial PY motif and resulting in reduced inactivation of the ENaCs. Aside from the proband, eight family members carried the mutation. Intra-familial phenotypic heterogeneity was observed in the blood pressure and serum potassium levels. Amiloride therapy combined with a low sodium diet is effective to alleviate the symptoms of patients with Liddle syndrome.

Conclusion: c.1691_1693delinsG, a novel frame-shift mutation in the β subunit of ENaC, was identified in a Chinese family with Liddle syndrome by whole-exome sequencing. Phenotypic heterogeneity can make diagnosis of Liddle syndrome difficult on the basis of clinical or biochemical characteristics alone. Genetic analysis is a useful tool allowing timely and accurate diagnosis of Liddle syndrome and playing a guiding role in precise treatment of the disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239342PMC
http://dx.doi.org/10.3389/fcvm.2022.896564DOI Listing

Publication Analysis

Top Keywords

liddle syndrome
24
novel frame-shift
16
frame-shift mutation
16
identified chinese
8
chinese family
8
characterized early-onset
8
responsible liddle
8
whole-exome sequencing
8
family members
8
phenotypic heterogeneity
8

Similar Publications

Liddle syndrome (LS) is an autosomal dominant genetic disorder characterized by early onset hypertension, hypokalemia, and low plasma aldosterone or renin concentration. It is caused by mutations in subunits of the epithelial sodium channel (ENaC). The clinical phenotypes of LS are variable and nonspecific, making it prone to both misdiagnosis and missed diagnosis.

View Article and Find Full Text PDF

Young Athlete With Hypertension and Hypokalemia.

Hypertension

November 2024

Department of Nephrology, INSERM EnVI U1096, CHU Rouen, CIC-CRB 1404 (D.G.), University of Rouen Normandy, France.

We describe a 17-year-old woman diagnosed with severe hypertension during routine follow-up after the prescription of a combined oral contraceptive pill. Initially, due to her age, the estradiol-containing contraception, and high-level sport practice, physicians suspected drug-induced hypertension. Blood tests showed hypokalemia, and further investigations revealed pseudoaldosteronism.

View Article and Find Full Text PDF

3--18-Glycyrrhetinic Acid or Its Glucuronide, the Metabolites of Glycyrrhizinic Acid with Individual Differences, Correlated with Diagnostic Marker for Licorice-Induced Pseudoaldosteronism in Humans.

Drug Metab Dispos

November 2024

Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-Dori, Mizuho-ku, Nagoya, Japan (R.S., K.I., Y.T., T.M.); Center for Kampo Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan (T.Y., K.F., K.W.); Department of Japanese Oriental (Kampo) Medicine, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, Japan (T.N.); Department of Japanese Traditional (Kampo) Medicine, Kanazawa University Hospital, 13-1 Takaramachi, Kanazawa-City, Ishikawa, Japan (K.O.-O.); Kampo Clinical Center, Hiroshima University Hospital, 1-2-3, Kasumi, Minami-ku, Hiroshima, Japan (K.O.-O.); Department of Oriental Medicine, Kameda Medical Center, 929 Higashi-cho, Kamogawa, Chiba, Japan (K.M.); Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan (K.F.)

Article Synopsis
  • Licorice is commonly used in traditional Japanese medicine and as a sweetener, but it can cause a side effect known as pseudoaldosteronism (PsA), which leads to symptoms like low potassium, high blood pressure, and fluid retention.
  • A study examined 78 patients using Kampo medicines with licorice, finding multiple glycyrrhizinic acid metabolites in their blood and urine, including some newly identified ones.
  • Individual differences were noted in the levels of these metabolites, suggesting they may influence susceptibility to PsA, with specific metabolites like 3--GA and 3-GA30G potentially playing a significant role.
View Article and Find Full Text PDF

Chronic kidney disease (CKD) is characterized by a steady decline in kidney function and affects roughly 10% of the world's population. This review focuses on the critical function of cyclic adenosine monophosphate (cAMP) signaling in CKD, specifically how it influences both protective and pathogenic processes in the kidney. cAMP, a critical secondary messenger, controls a variety of cellular functions, including transcription, metabolism, mitochondrial homeostasis, cell proliferation, and apoptosis.

View Article and Find Full Text PDF
Article Synopsis
  • Liddle syndrome is a genetic condition that causes early-onset high blood pressure, low potassium levels, and other hormonal imbalances due to mutations in genes responsible for sodium channels, primarily SCNN1A.
  • A case from China involved a 59-year-old man with a long history of uncontrolled hypertension and low potassium, which was linked to a rare mutation in the SCNN1A gene identified through genetic testing.
  • The patient showed significant improvement in potassium levels and blood pressure after treatment with triamterene, highlighting the importance of genetic testing in diagnosing conditions like Liddle syndrome.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!